Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib

por Shivapurkar, Narayan, Vietsch, Eveline E., Carney, Erin, Isaacs, Claudine, Wellstein, Anton
Publicado 2017

PLAC1 as a serum biomarker for breast cancer

por Yuan, Hongyan, Chen, Vincent, Boisvert, Marc, Isaacs, Claudine, Glazer, Robert I.
Publicado 2018

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics

por Chandler, Young, Schechter, Clyde, Jayasekera, Jinani, Isaacs, Claudine, Kurian, Allison W., Cadham, Christopher, Mandelblatt, Jeanne
Publicado 2021

Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis

por Xiao, Jerry, Pohlmann, Paula R., Isaacs, Claudine, Weinberg, Benjamin A., He, Aiwu R., Schlegel, Richard, Agarwal, Seema
Publicado 2021

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS

por Sulayman, Nadiyah, Spellman, Elizabeth, Graves, Kristi D., Peshkin, Beth N., Isaacs, Claudine, Schwartz, Marc D., O'Neill, Suzanne C.
Publicado 2012

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise o...

por Evans, Chalanda, Hamilton, Rebekah J., Tercyak, Kenneth P., Peshkin, Beth N., Rabemananjara, Kantoniony, Isaacs, Claudine, O’Neill, Suzanne C.
Publicado 2016

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer

por Jayasekera, Jinani, Sparano, Joseph A, Gray, Robert, Isaacs, Claudine, Kurian, Allison, O’Neill, Suzanne, Schechter, Clyde B, Mandelblatt, Jeanne
Publicado 2019

Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions

por Jayasekera, Jinani, Sparano, Joseph A., O'Neill, Suzanne, Chandler, Young, Isaacs, Claudine, Kurian, Allison W., Kushi, Lawrence, Schechter, Clyde B., Mandelblatt, Jeanne
Publicado 2021

Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers

por Hooker, Gillian W, King, Lesley, VanHusen, Lauren, Graves, Kristi, Peshkin, Beth N, Isaacs, Claudine, Taylor, Kathryn L, Poggi, Elizabeth, Schwartz, Marc D
Publicado 2014

Results of a randomized controlled trial of a decision support intervention for disclosing maternal BRCA genetic test results to children and adolescents

por Tercyak, Kenneth P., DeMarco, Tiffani A., Schneider, Katherine A., Luta, George, Isaacs, Claudine, Garber, Judy E., Sleiman, Marcelo M., Yockel, Mary Rose, Peshkin, Beth N.
Publicado 2023

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast c...

por Lynce, Filipa, Saleh, Mervat, Shajahan-Haq, Ayesha, Gallagher, Christopher, Dilawari, Asma, Hahn, Olwen, Abu-Khalaf, Maysa, Cai, Ling, Pohlmann, Paula, Mohebtash, Mahsa, Kamugisha, Lois, Isaacs, Claudine
Publicado 2018

Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report

por O’Neill, Suzanne C., Hamilton, Jada G., Conley, Claire C., Peshkin, Beth N., Sacca, Rosalba, McDonnell, Glynnis A., Isaacs, Claudine, Robson, Mark E., Tercyak, Kenneth P.
Publicado 2021

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65

por O’Neill, Suzanne C., Isaacs, Claudine, Lynce, Filipa, Graham, Deena Mary Atieh, Chao, Calvin, Sheppard, Vanessa B., Zhou, Yingjun, Liu, Chunfu, Selvam, Nandini, Schwartz, Marc D., Potosky, Arnold L.
Publicado 2017

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

por Jayasekera, Jinani, Zhao, Amy, Schechter, Clyde, Lowry, Kathryn, Yeh, Jennifer M., Schwartz, Marc D., O'Neill, Suzanne, Wernli, Karen J., Stout, Natasha, Mandelblatt, Jeanne, Kurian, Allison W., Isaacs, Claudine
Publicado 2023

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

por Desai, Neelam V., Barrows, Elizabeth D., Nielsen, Sarah M., Hatchell, Kathryn E., Anderson, Michael J., Haverfield, Eden V., Herrera, Blanca, Esplin, Edward D., Lucassen, Anneke, Tung, Nadine M., Isaacs, Claudine
Publicado 2023

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

por Kotsopoulos, Joanne, Olopado, Olufunmilayo I, Ghadirian, Parviz, Lubinski, Jan, Lynch, Henry T, Isaacs, Claudine, Weber, Barbara, Kim-Sing, Charmaine, Ainsworth, Peter, Foulkes, William D, Eisen, Andrea, Sun, Ping, Narod, Steven A
Publicado 2005

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer

por Khoury, Katia, Tan, Antoinette R., Elliott, Andrew, Xiu, Joanne, Gatalica, Zoran, Heeke, Arielle L., Isaacs, Claudine, Pohlmann, Paula R., Schwartzberg, Lee S., Simon, Michael, Korn, W. Michael, Swain, Sandra M., Lynce, Filipa
Publicado 2020

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk

por Ricks-Santi, Luisel J, Sucheston, Lara E, Yang, Yang, Freudenheim, Jo L, Isaacs, Claudine J, Schwartz, Marc D, Dumitrescu, Ramona G, Marian, Catalin, Nie, Jing, Vito, Dominica, Edge, Stephen B, Shields, Peter G
Publicado 2011

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab,...

por Pohlmann, Paula R., Graham, Deena, Wu, Tianmin, Ottaviano, Yvonne, Mohebtash, Mahsa, Kurian, Shweta, McNamara, Donna, Lynce, Filipa, Warren, Robert, Dilawari, Asma, Rao, Suman, Mainor, Candace, Swanson, Nicole, Tan, Ming, Isaacs, Claudine, Swain, Sandra M.
Publicado 2022

BRCA1 deficiency in mature CD8(+) T lymphocytes impairs antitumor immunity

por Wu, Bogang, Qi, Leilei, Chiang, Huai-Chin, Pan, Haihui, Zhang, Xiaowen, Greenbaum, Alexandra, Stark, Elizabeth, Wang, Li-Ju, Chen, Yidong, Haddad, Bassem R., Clagett, Dionyssia, Isaacs, Claudine, Elledge, Richard, Horvath, Anelia, Hu, Yanfen, Li, Rong
Publicado 2023